18 results
10-K
2022 FY
OBSVF
ObsEva SA
31 Mar 23
Annual report
4:01pm
sufficient quantities of our products candidates or receive raw materials in a timely manner, we could be required to delay our ongoing clinical trials … for the foreseeable future. There are a limited number of suppliers for raw materials that we use to manufacture our drugs and there may be a need to assess
6-K
EX-99.1
p5y7ez5
7 Aug 19
Current report (foreign)
7:21am
20-F
pcuxlenuuv
21 Apr 17
Annual report (foreign)
12:00am
F-1
EX-10.2
z8hlq3hn8ty6 jajjn
30 Dec 16
Registration statement (foreign)
12:00am
F-1
u6siz
30 Dec 16
Registration statement (foreign)
12:00am
F-1
EX-10.1
z8p26r2c2ue
30 Dec 16
Registration statement (foreign)
12:00am
DRS
xrk2qn5yoatr v9qhw1
14 Oct 16
Draft registration statement
12:00am
DRS
EX-10
8gjfg47 tyz
14 Oct 16
Draft registration statement
12:00am
DRS
EX-10
b26teo1vzmcc9eoql6d
14 Oct 16
Draft registration statement
12:00am
- Prev
- 1
- Next